DI PASCOLI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.505
EU - Europa 288
AS - Asia 251
SA - Sud America 1
Totale 3.045
Nazione #
US - Stati Uniti d'America 2.504
CN - Cina 148
IT - Italia 103
FI - Finlandia 48
SG - Singapore 48
SE - Svezia 36
VN - Vietnam 35
GB - Regno Unito 31
DE - Germania 21
FR - Francia 21
IN - India 15
UA - Ucraina 12
NL - Olanda 5
IE - Irlanda 3
AT - Austria 2
HK - Hong Kong 2
TR - Turchia 2
BG - Bulgaria 1
BR - Brasile 1
CA - Canada 1
GR - Grecia 1
HU - Ungheria 1
JP - Giappone 1
LT - Lituania 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 3.045
Città #
Fairfield 496
Woodbridge 310
Houston 240
Ann Arbor 224
Ashburn 190
Wilmington 161
Cambridge 155
Seattle 136
Chandler 129
Jacksonville 53
Princeton 48
Padova 47
San Diego 46
Singapore 35
Dong Ket 34
Beijing 33
Medford 30
Nanjing 26
Des Moines 23
Helsinki 17
Roxbury 17
Boardman 15
Pune 15
Jinan 10
Dallas 9
Guangzhou 9
London 9
Hebei 7
Kunming 7
Nanchang 7
Cagliari 6
Dearborn 6
Jiaxing 6
Santa Clara 6
Shenyang 6
Changsha 5
New York 5
Norwalk 5
Chicago 4
Venice 4
Dublin 3
Falls Church 3
Hounslow 3
Lanzhou 3
Milan 3
Pesaro 3
Redwood City 3
Rome 3
Tianjin 3
Alghero 2
Changchun 2
Chiswick 2
Erzurum 2
Florence 2
Frankfurt am Main 2
Hangzhou 2
Hefei 2
Hong Kong 2
Lappeenranta 2
Mondolfo 2
Monteroni di Lecce 2
Ogden 2
Paris 2
Vienna 2
Wuhan 2
Amsterdam 1
Arezzo 1
Athens 1
Auburn Hills 1
Baotou 1
Belgrade 1
Bergamo 1
Budapest 1
Chengdu 1
Chongqing 1
Council Bluffs 1
Cutrofiano 1
Esslingen am Neckar 1
Falkenstein 1
Fort Worth 1
Freeport 1
Genoa 1
Haikou 1
Hanoi 1
Kharkiv 1
Kilburn 1
Lignana 1
Los Angeles 1
Maserà Di Padova 1
Mestre 1
Milton Keynes 1
Ningbo 1
Noci 1
Nottingham 1
Palermo 1
Pancalieri 1
Phoenix 1
Potenza 1
Prineville 1
Radeberg 1
Totale 2.685
Nome #
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 176
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 146
Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report 125
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation 119
Chronic CO levels has a beneficial effect on vascular relaxation in diabetes 114
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites 110
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 109
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats 103
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats. 99
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis 99
Clinical role of non-invasive assessment of portal hypertension 97
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase 96
Why and how to measure renal function in patients with liver disease 95
Use of early-TIPS for high-risk variceal bleeding: Results of a post-RCT surveillance study 93
Carbon monoxide-mediated activation of a large-conductance calcium-activated potassium channels contrinutes to mesenteric vasodilation in cirrhotic rats. 321 : 187-194. 91
Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats 91
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats with ascites 88
Heme oxygenase regulates the response of intrarenal arteries to alpha-adrenergic stimulation in experimental cirrhosis. 88
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis. 88
Heme Oxygenase (HO) mediates hyporeactivity to phenylephrine (PE) in mesenteric vessels of experimental cirrhosis with ascites 87
Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts 81
Renin-angiotensin-aldosterone system in cirrhosis: There's room to try! 74
Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis 73
Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats 72
Peculiar characteristics of portal-hepatic hemodynamics of alcoholic cirrhosis. 67
Heme oxygenase (HO) mediates hyporeactivity to phenylephrine (PE) in mesenteric vessels of experimental cirrhosis with ascites 64
Contribution of Splenic Resistance Arteries to Splanchnic Blood Overflow in Cirrhosis 63
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data 60
null 59
Hepatic osteodystrophy. 57
Resveratrol administration improves intrahepatic endothelial dysfunction and reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats 57
EETs and HO-1 cross-talk 55
Mitochondria-targeted antioxidant mitoquinone attenuates liver inflammation and fibrosis in cirrhotic rats 55
Prevention of endothelial cell dysfunction and apoptosis through the induction of heme oxygenase-1 normalizes blood pressure in diabetic spontaneously hypertensive rats 42
Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3 21
Combined Pharmacological and Endoscopic Treatment for Worsening Gastroesophageal Varices in Patients with Cirrhosis 15
Clinical role of non-invasive assessment of portal hypertension 14
Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice 13
Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites 11
Heme oxygenase (HO) mediates hyporeactivity to phenylephrine (PE) in mesenteric vessels of experimental cirrhosis with ascites. 10
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis 7
Prognostic value of procalcitonin in patients with cirrhosis hospitalized for acute infection 1
Totale 3.085
Categoria #
all - tutte 12.206
article - articoli 11.660
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020594 0 0 20 63 60 46 101 76 89 59 46 34
2020/2021553 22 52 7 50 22 17 31 50 72 133 43 54
2021/2022493 18 34 86 38 17 40 21 60 28 8 48 95
2022/2023287 72 24 0 20 66 34 1 17 20 4 25 4
2023/2024214 4 30 26 33 12 24 21 14 6 4 18 22
2024/202567 1 41 25 0 0 0 0 0 0 0 0 0
Totale 3.085